Deep Tech Startups

ZettaJoule develops advanced small modular reactors based on modernized high-temperature gas-cooled reactor (HTGR) technology, drawing on operating data from Japan's HTTR. Its helium-cooled, graphite-moderated ZJ reactor is designed to generate high-temperature heat up to 950 °C and electricity for industrial and commercial sectors such as oil and gas, chemical manufacturing, mining, steelmaking, and data centers.

1 investor

Shanghai Zhenge Biotech is an independent CDMO company providing contract development and manufacturing services for biopharmaceutical clients during clinical development and commercialization phases. The company offers a comprehensive range of services including drug development, cell line construction, process development, analytical methods, raw material production, drug formulation, stability studies, and animal cell culture media development.

1 investor

A company developing embodied artificial intelligence and general-purpose robots for real-world production and service environments. The company builds a full-stack technology system combining robot hardware, intelligent algorithms, and an open platform to enable robots to perform diverse tasks in complex, dynamic real-world settings.

1 investor

Zilift developed permanent-magnet, electrically driven artificial lift technologies for oil and gas wells, including the SpeedDrive through-tubing ESP deployment system and the TorqueDrive electric submersible PCP system for rigless production restoration. The company was acquired by Schlumberger (now SLB) in 2021, and its technologies are now part of SLB's artificial lift portfolio.

1 investor

Zing develops hardware detection systems and cloud software for drone airspace identification and compliance. The company offers Remote ID detection devices, broadcast modules for drone compliance, and a platform for airspace awareness and monitoring.

1 investor

Zinite develops thin-film transistor technology that can be built along the z-axis to enable 3D chips for the semiconductor industry. Its node- and substrate-agnostic transistors aim to deliver more performance per area and integrate with existing fabrication factories.

1 investor

Zip Infrastructure develops Zippar, a next-generation autonomous urban ropeway transit system that runs on independent ropes and gondolas to allow curves and branching, marketed to municipalities and companies as a lower-cost alternative to monorails. The Japan-based company promotes the system for reducing traffic congestion and providing accessible transit stations.

1 investor

ZKM builds zero-knowledge proof infrastructure, including its Entangled Rollups technology, for blockchain networks. It provides technical documentation, whitepapers, and educational resources focused on the Bitcoin economy and rollup systems.

1 investor

ZModal builds infrastructure and software for real-time, model-driven biomanufacturing processes. The company serves biotech and pharmaceutical manufacturers seeking to optimize regulated production of biologics and living tissues.

1 investor

ZOECORE is a farming technology product that increases crop profitability for agricultural operations. The company targets farms across North America with a focus on cannabis cultivation.

1 investor

ZSFab manufactures porous titanium spinal implants featuring hierarchical lattice architectures designed to support bone integration and reduce subsidence risk in cervical and lumbar fusion procedures. The InterConnect™ system combines optimized porosity, surface texturing, and biomimetic structural design for orthopedic surgeons and spinal fusion patients.

1 investor

Zuri develops hybrid-electric uncrewed cargo vertical take-off and landing (VTOL) aircraft, with plans to expand toward a certified six-seater passenger variant. The company designs and manufactures aircraft in-house in Prague, targeting commercial cargo deliveries beginning in 2027-2029.

1 investor

Narnia Labs builds AslanX, a generative and agentic AI platform for manufacturing that automates the repeated design, simulation, and evaluation steps of product development. It generates novel component geometries and predicts their engineering performance in seconds, targeting use cases such as automotive brake parts, wheels, and jet engine brackets.

1 investor

NeoCannBio is a technology spin-off from KIST developing cannabinoid-based pharmaceuticals and producing hemp-derived cannabinoid drug ingredients, including high-purity CBD via microwave processing and GMP production. The company builds a broad cannabinoid library and develops new drugs for patients with rare and intractable diseases in Korea.

1 investor

Novelty Nobility develops antibody and protein therapeutics for clinical applications. The company's leadership team brings expertise in immunization, affinity maturation, and biopharmaceutical development across therapeutic areas including ophthalmology.

1 investor

Novorex is a drug discovery company that combines AI, fragment-based drug discovery (FBDD), and biophysical validation (SPR, NMR, X-ray crystallography, and wet-lab assays) to develop novel small-molecule therapeutics. It operates in-house CNS and inflammation pipelines with R&D labs in Pangyo, Central, and Jeongeup.

1 investor

NeuroVenti is a biotech company developing neuroprotective and therapeutic agents for neuronal and central nervous system disorders, including a drug candidate (NV01-A02) for autism spectrum disorder currently in domestic Phase 2 clinical trials. It also offers preclinical CDRO services such as candidate discovery, preclinical research consulting, and efficacy and safety evaluation.

1 investor

Deediim develops machine vision sensors for surface inspection, using free-illumination and surface-property-imaging technology to detect defects. The system is aimed at industrial quality inspection and manufacturing applications.

1 investor

LigaChemBio is a biotechnology company focused on drug development, particularly in ADC (antibody-drug conjugate) and small molecule therapeutics. The company develops and partners on therapeutic pipelines for pharmaceutical applications.

1 investor

MicrobiotiX develops bacteriophage-based therapeutics targeting multi-drug resistant bacterial infections, including WHO/CDC priority pathogens such as Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, and E. coli. The company operates a phage discovery and development platform with a library of about 1,000 bacteriophages, in-silico modules, and GMP production facilities, and its lead pipeline MP101 has entered clinical trials with first-patient-in completed.

1 investor

McScience manufactures test systems and scientific measurement equipment for research and development across OLED, solar cells, batteries, and flexible electronics. The company supplies to academic institutions and industrial companies in over 100 countries.

1 investor

MEPSGEN develops microphysiological systems (MPS) and organ-on-chip technologies for drug development and testing, serving pharmaceutical companies and contract research organizations. The company manufactures nanoparticles and microspheres, produces automated robotic systems for MPS modeling, and develops nanomedicines for diseases including glioblastoma and Alzheimer's disease.

1 investor

MUZLIVE develops KiT, a smart media format that bridges physical music albums and digital devices, allowing fans to own and interact with artist albums through smart devices. The company also offers KiT Video for DVD content and is expanding into books, merchandise, and other media formats.

1 investor

Cellebrain is a biotech company developing stem cell-based gene therapies for intractable diseases that currently lack pharmacological treatments. It focuses on gene-cell therapies aimed at improving the quality of life for patients with cancer and chronic diseases.

1 investor